Preview Mode Links will not work in preview mode

Jul 25, 2024

Featuring an interview with Dr Jonathan W Goldman, including the following topics:

  • Contemporary and Future Care for Patients with Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation (0:00)
  • Evolving First-Line Treatment for Metastatic NSCLC with an EGFR Mutation (21:05)
  • Other Emerging Strategies for Relapsed Metastatic Lung Cancer (29:16)
  • Emerging Role of Antibody-Drug Conjugates in the Management of NSCLC with an EGFR Mutation (37:59)
  • Current and Future Management of NSCLC with an EGFR Exon 20 Insertion Mutation (45:29)

CME information and select publications